Revisiting regulatory T cells for stroke therapy.

Area of Science:

• Neuroimmunology
• Stroke research
• T cell biology

Background:

• Stroke is a major cause of death and disability.
• T cells play a complex role in post-stroke immunity and inflammation.
• Understanding early immune responses is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of early lymphocyte infiltration after ischemic stroke.
• To identify specific T cell subtypes involved in the acute phase of stroke.
• To evaluate the therapeutic potential of CD8+ regulatory-like T cells (CD8+ TRLs) in stroke models.

Main Methods:

• Experimental ischemic stroke model in mice.
• Flow cytometry and immune cell profiling.
• Assessment of brain damage and functional recovery.

Main Results:

• CD8+ TRLs were among the first lymphocytes to infiltrate the brain post-stroke.
• Administration of CD8+ TRLs reduced brain infarction and improved functional outcomes.
• These effects were observed in both young and aged mice.

Conclusions:

• CD8+ TRLs represent a novel, early-acting regulatory immune cell population in stroke.
• Targeting CD8+ TRLs shows promise for mitigating stroke-induced brain injury.
• These cells may also be relevant in other T cell-mediated neurological conditions.